Autosomal recessive hypertrophic cardiomyopathy associated with variants in TRIM63
<h2>Abstract</h2><h3>Background</h3> Hypertrophic cardiomyopathy (HCM) is typically linked to dominant variants in sarcomeric genes, but rare minor genes, including <i>TRIM63</i> coding for an E3 ubiquitin-protein ligase, have recently emerged as potential causes of recessive HCM. <h3>Methods and results</h3> Among 517 adult patients with clinical HCM who underwent next-generation sequencing, we found six index cases carrying biallelic <i>TRIM63</i> variants—four homozygous and two compound heterozygous. They presented with early-onset disease, marked concentric hypertrophy, diffuse myocardial fibrosis, and progressive left ventricular dysfunction. One patient underwent heart transplantation. No cardiac disease was found in heterozygous relatives. <h3>Conclusions</h3> <i>TRIM63</i>-related HCM is rare but clinically distinct. Early identification of <i>TRIM63</i> homozygous and two compound heterozygous variants in HCM is crucial and warrants proactive clinical surveillance. <b>Take home messages:</b><ul><li>•TRIM63-related HCM is a rare autosomal-recessive subtype with early onset and severe phenotypes.</li><li>•Rapid disease progression is common, with extensive fibrosis and frequent transition to hypokinetic-dilated end-stage cardiomyopathy.</li><li>•Early genetic diagnosis supports proactive management, including timely ICD implantation for arrhythmia risk and reproductive counselling for families due to the recessive inheritance.</li></ul>
Authors
- Natascia Cerrato
- Fernando Bonanni
- Francesca Girolami (ORCID: https://orcid.org/0000-0001-9143-3597)
- Mattia Zampieri (ORCID: https://orcid.org/0000-0002-1140-134X)
- V. Barletta
- Silvia Passantino
- Alessia Gozzini (ORCID: https://orcid.org/0000-0003-4800-0862)
- Alberto Marchi
- Giulia Forzano
- Maurizio Cecconi (ORCID: https://orcid.org/0000-0002-4376-6538)
- Laura Dosa
- A. Ballerini
- ED Palinkas
- Olivotto
Institutions
- Scuola Superiore Sant'Anna (IT)
- University of Szeged (HU)
- Istituto Giannina Gaslini (IT)
- Azienda Sanitaria Locale di Asti (IT)
- Meyer Children's Hospital (IT)
- Istituti di Ricovero e Cura a Carattere Scientifico (IT)
- Azienda Usl Toscana Centro (IT)
Publication Details
- Journal
- International Journal of Cardiology
- Published
- 2025-11-05
- DOI
- https://doi.org/10.1016/j.ijcard.2025.134010
- Citations
- 1
- Primary Topic
- Cardiomyopathy and Myosin Studies
- Type
- article
- Field-Weighted Citation Impact
- 1.39
Funders
- Bristol-Myers Squibb
- Sanofi
- Boston Scientific Corporation
- Cytokinetics
- Amicus Therapeutics
- European Commission
- Sanofi Genzyme
- HORIZON EUROPE Framework Programme